Table 3.

Multivariable Risk Factors of Post-transplant Graft Loss in the Current Era

Risk factors	HR	95% CI	p-value
Race (reference: Caucasians)
African American	1.12	0.86–1.47	0.39
Hispanic	0.87	0.65–1.16	0.33
Asian	1.09	0.60–1.96	0.78
Other	1.12	0.67–1.88	0.66
Diagnosis (reference: CMP)
CHD	2.07	1.65–2.59	<0.001
Other	1.01	0.37–2.73	0.99
Bilirubin ≥2 mg/dL	1.71	1.32–2.21	<0.001
Albumin ≤3.5 g/dL	1.27	1.03–1.58	0.029
ECMO	1.53	1.09–2.14	0.015
Infection requiring IV drug therapy within 2 weeks prior to transplant	1.47	1.16–1.87	0.001
Medicaid	1.36	1.10–1.69	0.005
Male donor	1.33	1.07–1.65	0.010
Ischemic time >3.5 hours	1.37	1.10–1.70	0.004

Boldface P values are statistically significant at P < 0.05.

CMP, cardiomyopathy; CHD, congenital heart disease; ECMO, extracorporeal membrane oxygenation; IV, intravenous.